719 — Shandong Xinhua Pharmaceutical Co Share Price
Last trade - 00:00- HK$3.67bn
- HK$5.10bn
- CNY8.10bn
- 73
- 93
- 15
- 69
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.74 | ||
| Price to Tang. Book | 0.84 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.42 | ||
| EV to EBITDA | 4.5 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.14% | ||
| Return on Equity | 11.44% | ||
| Operating Margin | 6.54% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 5,606.02 | 6,005.59 | 6,560.08 | 7,502.99 | 8,100.84 | n/a | n/a | 9.08% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +11.6 | +8.77 | +5.81 | +10.95 | +16.74 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.
Directors
- Daiming Zhang CHM (58)
- Ning Hou CFO (42)
- Tongqing He DGM (51)
- Deqing Du DGM (50)
- Changsheng Wei DGM
- Wenhui Xu DGM
- Zhonghui Zheng DGM
- Chit Fun So CTR (45)
- Deping Du EDR (51)
- Xiaolong Wang OTH (50)
- Kechun Cong NED (56)
- Lie Xu NED (55)
- Wah Wai Lo NID (57)
- Guangcheng Pan NID (72)
- Jianwei Zhu NID (64)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 30th, 1993
- Public Since
- December 31st, 1996
- No. of Shareholders
- 97,594
- No. of Employees
- 7,104
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 682,407,635
- Address
- No. 1 Lutai Avenue, ZIBO, 255086
- Web
- http://www.xhzy.com
- Phone
- +86 5332166666
- Contact
- Changqiu Cao
- Auditors
- ShineWing Certified Public Accountants
Upcoming Events for 719
Similar to 719
3D Medicines
Stock Exchange of Hong Kong Limited
3SBio
Stock Exchange of Hong Kong Limited
AIM Vaccine Co
Stock Exchange of Hong Kong Limited
Ascletis Pharma
Stock Exchange of Hong Kong Limited
Asymchem Laboratories Tianjin Co
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:19 UTC, shares in Shandong Xinhua Pharmaceutical Co are trading at HK$5.38. This share price information is delayed by 15 minutes.
Shares in Shandong Xinhua Pharmaceutical Co last closed at HK$5.38 and the price had moved by -16.33% over the past 365 days. In terms of relative price strength the Shandong Xinhua Pharmaceutical Co share price has underperformed the FTSE Developed Asia Pacific Index by -15.75% over the past year.
There is no consensus recommendation for this security.
The Shandong Xinhua Pharmaceutical Co dividend yield is 5.03% based on the trailing twelve month period.
Last year, Shandong Xinhua Pharmaceutical Co paid a total dividend of CNY0.25, and it currently has a trailing dividend yield of 5.03%. We do not have any data on when Shandong Xinhua Pharmaceutical Co is to next pay dividends.
We do not have data on when Shandong Xinhua Pharmaceutical Co is to next pay dividends. The historic dividend yield on Shandong Xinhua Pharmaceutical Co shares is currently 5.03%.
To buy shares in Shandong Xinhua Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$5.38, shares in Shandong Xinhua Pharmaceutical Co had a market capitalisation of HK$3.67bn.
Here are the trading details for Shandong Xinhua Pharmaceutical Co:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 719
Based on an overall assessment of its quality, value and momentum Shandong Xinhua Pharmaceutical Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shandong Xinhua Pharmaceutical Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -13.96%.
As of the last closing price of HK$5.38, shares in Shandong Xinhua Pharmaceutical Co were trading -3.81% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Shandong Xinhua Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$5.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Shandong Xinhua Pharmaceutical Co's management team is headed by:
- Daiming Zhang - CHM
- Ning Hou - CFO
- Tongqing He - DGM
- Deqing Du - DGM
- Changsheng Wei - DGM
- Wenhui Xu - DGM
- Zhonghui Zheng - DGM
- Chit Fun So - CTR
- Deping Du - EDR
- Xiaolong Wang - OTH
- Kechun Cong - NED
- Lie Xu - NED
- Wah Wai Lo - NID
- Guangcheng Pan - NID
- Jianwei Zhu - NID